{"entity":{"type":"insider","cik":"0001760648","url":"/insider/0001760648","json_url":"/insider/0001760648.json","name":"OrbiMed Capital GP VII LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":188,"n_filings":63,"first":"2018-12-13","last":"2026-06-24","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Capital GP VII LLC","source":"filing","n_filings":63,"first_seen":"2018-12-13","last_seen":"2026-06-24"}],"transactions":[{"id":5768402,"accession":"0000947871-26-000653","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-26-000653","line_url":"/filing/0000947871-26-000653","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":860123.0,"shares_display":"860,123","price_per_share":45.35868195595281,"price_display":"45.36","price_state":"stated","total_value":39014045.6,"total_display":"39,014,045.60","total_whole":"39,014,046","shares_owned_after":6601878.0,"shares_owned_after_display":"6,601,878","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-22","filed_date":"2026-06-24","scope":"insider","n_lines":4},{"id":5937343,"accession":"0000947871-26-000637","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000637","line_url":"/filing/0000947871-26-000637","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":281408.0,"shares_display":"281,408","price_per_share":45.02,"price_display":"45.02","price_state":"stated","total_value":12668988.16,"total_display":"12,668,988.16","total_whole":"12,668,988","shares_owned_after":7388902.0,"shares_owned_after_display":"7,388,902","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider","n_lines":2},{"id":6217411,"accession":"0000947871-26-000593","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000593","line_url":"/filing/0000947871-26-000593","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Q32 Bio Inc.","issuer_ticker":"QTTB","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1875000.0,"shares_display":"1,875,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":3502987.0,"shares_owned_after_display":"3,502,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-05-28","filed_date":"2026-06-01","scope":"insider","n_lines":2},{"id":4904873,"accession":"0000947871-25-000629","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000629","line_url":"/filing/0000947871-25-000629#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":213257.0,"shares_display":"213,257","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":70374.81,"total_display":"70,374.81","total_whole":"70,375","shares_owned_after":6066343.0,"shares_owned_after_display":"6,066,343","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-26","filed_date":"2025-06-26","scope":"insider"},{"id":4904869,"accession":"0000947871-25-000629","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000629","line_url":"/filing/0000947871-25-000629#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138800.0,"shares_display":"138,800","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":45804.0,"total_display":"45,804.00","total_whole":"45,804","shares_owned_after":6279600.0,"shares_owned_after_display":"6,279,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-25","filed_date":"2025-06-26","scope":"insider"},{"id":4904865,"accession":"0000947871-25-000629","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000629","line_url":"/filing/0000947871-25-000629#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":231600.0,"shares_display":"231,600","price_per_share":0.35,"price_display":"0.35","price_state":"stated","total_value":81060.0,"total_display":"81,060.00","total_whole":"81,060","shares_owned_after":6418400.0,"shares_owned_after_display":"6,418,400","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider"},{"id":4658188,"accession":"0000947871-25-000423","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000423","line_url":"/filing/0000947871-25-000423#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68195.0,"shares_display":"68,195","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":21822.4,"total_display":"21,822.40","total_whole":"21,822","shares_owned_after":6650000.0,"shares_owned_after_display":"6,650,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-24","filed_date":"2025-04-24","scope":"insider"},{"id":4658180,"accession":"0000947871-25-000423","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000423","line_url":"/filing/0000947871-25-000423#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89328.0,"shares_display":"89,328","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":30371.52,"total_display":"30,371.52","total_whole":"30,372","shares_owned_after":6718195.0,"shares_owned_after_display":"6,718,195","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-23","filed_date":"2025-04-24","scope":"insider"},{"id":4658175,"accession":"0000947871-25-000423","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000423","line_url":"/filing/0000947871-25-000423#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78049.0,"shares_display":"78,049","price_per_share":0.34,"price_display":"0.34","price_state":"stated","total_value":26536.66,"total_display":"26,536.66","total_whole":"26,537","shares_owned_after":6807523.0,"shares_owned_after_display":"6,807,523","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-22","filed_date":"2025-04-24","scope":"insider"},{"id":4027061,"accession":"0000947871-25-000415","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000415","line_url":"/filing/0000947871-25-000415#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":77090.0,"shares_display":"77,090","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":25439.7,"total_display":"25,439.70","total_whole":"25,440","shares_owned_after":6885572.0,"shares_owned_after_display":"6,885,572","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-17","filed_date":"2025-04-17","scope":"insider"},{"id":4027060,"accession":"0000947871-25-000415","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000415","line_url":"/filing/0000947871-25-000415#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61638.0,"shares_display":"61,638","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":20340.54,"total_display":"20,340.54","total_whole":"20,341","shares_owned_after":6962662.0,"shares_owned_after_display":"6,962,662","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-16","filed_date":"2025-04-17","scope":"insider"},{"id":4027059,"accession":"0000947871-25-000415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000415","line_url":"/filing/0000947871-25-000415#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10326.0,"shares_display":"10,326","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":3923.88,"total_display":"3,923.88","total_whole":"3,924","shares_owned_after":7024300.0,"shares_owned_after_display":"7,024,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-04-15","filed_date":"2025-04-17","scope":"insider"},{"id":5105873,"accession":"0000947871-25-000199","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-25-000199","line_url":"/filing/0000947871-25-000199","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":143170.0,"shares_display":"143,170","price_per_share":10.84,"price_display":"10.84","price_state":"stated","total_value":1551962.8,"total_display":"1,551,962.80","total_whole":"1,551,963","shares_owned_after":747887.0,"shares_owned_after_display":"747,887","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-19","scope":"insider","n_lines":2},{"id":5105866,"accession":"0000947871-25-000199","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000199","line_url":"/filing/0000947871-25-000199","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47502.0,"shares_display":"47,502","price_per_share":9.868906572354849,"price_display":"9.87","price_state":"stated","total_value":468792.8,"total_display":"468,792.80","total_whole":"468,793","shares_owned_after":3205930.0,"shares_owned_after_display":"3,205,930","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-14","filed_date":"2025-02-19","scope":"insider","n_lines":2},{"id":4574528,"accession":"0000947871-25-000034","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000034","line_url":"/filing/0000947871-25-000034#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79024.0,"shares_display":"79,024","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":47414.4,"total_display":"47,414.40","total_whole":"47,414","shares_owned_after":7034626.0,"shares_owned_after_display":"7,034,626","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-14","filed_date":"2025-01-14","scope":"insider"},{"id":4574520,"accession":"0000947871-25-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000034","line_url":"/filing/0000947871-25-000034#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17986.0,"shares_display":"17,986","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":11511.04,"total_display":"11,511.04","total_whole":"11,511","shares_owned_after":7113650.0,"shares_owned_after_display":"7,113,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-13","filed_date":"2025-01-14","scope":"insider"},{"id":4574512,"accession":"0000947871-25-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000034","line_url":"/filing/0000947871-25-000034#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126209.0,"shares_display":"126,209","price_per_share":0.66,"price_display":"0.66","price_state":"stated","total_value":83297.94,"total_display":"83,297.94","total_whole":"83,298","shares_owned_after":7131636.0,"shares_owned_after_display":"7,131,636","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-10","filed_date":"2025-01-14","scope":"insider"},{"id":4747701,"accession":"0000947871-25-000021","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-25-000021","line_url":"/filing/0000947871-25-000021#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75007.0,"shares_display":"75,007","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":51004.76,"total_display":"51,004.76","total_whole":"51,005","shares_owned_after":7257845.0,"shares_owned_after_display":"7,257,845","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-08","scope":"insider"},{"id":4747697,"accession":"0000947871-25-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-25-000021","line_url":"/filing/0000947871-25-000021#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52536.0,"shares_display":"52,536","price_per_share":0.71,"price_display":"0.71","price_state":"stated","total_value":37300.56,"total_display":"37,300.56","total_whole":"37,301","shares_owned_after":7332852.0,"shares_owned_after_display":"7,332,852","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-08","scope":"insider"},{"id":4747692,"accession":"0000947871-25-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-25-000021","line_url":"/filing/0000947871-25-000021#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19481.0,"shares_display":"19,481","price_per_share":0.77,"price_display":"0.77","price_state":"stated","total_value":15000.37,"total_display":"15,000.37","total_whole":"15,000","shares_owned_after":7385388.0,"shares_owned_after_display":"7,385,388","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-08","scope":"insider"},{"id":2580217,"accession":"0000947871-24-001037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-001037","line_url":"/filing/0000947871-24-001037#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":230321.0,"shares_display":"230,321","price_per_share":0.6,"price_display":"0.60","price_state":"stated","total_value":138192.6,"total_display":"138,192.60","total_whole":"138,193","shares_owned_after":7404869.0,"shares_owned_after_display":"7,404,869","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-20","filed_date":"2024-12-26","scope":"insider"},{"id":3017333,"accession":"0000947871-24-000998","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-24-000998","line_url":"/filing/0000947871-24-000998#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80.0,"shares_display":"80","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":64.0,"total_display":"64.00","total_whole":"64","shares_owned_after":7635190.0,"shares_owned_after_display":"7,635,190","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-11","scope":"insider"},{"id":3017328,"accession":"0000947871-24-000998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000998","line_url":"/filing/0000947871-24-000998#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8015.0,"shares_display":"8,015","price_per_share":0.8,"price_display":"0.80","price_state":"stated","total_value":6412.0,"total_display":"6,412.00","total_whole":"6,412","shares_owned_after":7635270.0,"shares_owned_after_display":"7,635,270","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-11","scope":"insider"},{"id":3017319,"accession":"0000947871-24-000998","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000998","line_url":"/filing/0000947871-24-000998#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54181.0,"shares_display":"54,181","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":45512.04,"total_display":"45,512.04","total_whole":"45,512","shares_owned_after":7643285.0,"shares_owned_after_display":"7,643,285","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-09","filed_date":"2024-12-11","scope":"insider"},{"id":2818720,"accession":"0000947871-24-000995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000995","line_url":"/filing/0000947871-24-000995#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20903.0,"shares_display":"20,903","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":17140.46,"total_display":"17,140.46","total_whole":"17,140","shares_owned_after":7697466.0,"shares_owned_after_display":"7,697,466","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-06","scope":"insider"},{"id":2818713,"accession":"0000947871-24-000995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000995","line_url":"/filing/0000947871-24-000995#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":76200.0,"shares_display":"76,200","price_per_share":0.79,"price_display":"0.79","price_state":"stated","total_value":60198.0,"total_display":"60,198.00","total_whole":"60,198","shares_owned_after":7718369.0,"shares_owned_after_display":"7,718,369","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-04","filed_date":"2024-12-06","scope":"insider"},{"id":2457261,"accession":"0000947871-24-000769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000769","line_url":"/filing/0000947871-24-000769#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39300.0,"shares_display":"39,300","price_per_share":0.71,"price_display":"0.71","price_state":"stated","total_value":27903.0,"total_display":"27,903.00","total_whole":"27,903","shares_owned_after":7794569.0,"shares_owned_after_display":"7,794,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-19","filed_date":"2024-09-23","scope":"insider"},{"id":2541767,"accession":"0000947871-24-000763","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-24-000763","line_url":"/filing/0000947871-24-000763#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25631.0,"shares_display":"25,631","price_per_share":0.73,"price_display":"0.73","price_state":"stated","total_value":18710.63,"total_display":"18,710.63","total_whole":"18,711","shares_owned_after":7833869.0,"shares_owned_after_display":"7,833,869","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-18","filed_date":"2024-09-18","scope":"insider"},{"id":2541763,"accession":"0000947871-24-000763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000763","line_url":"/filing/0000947871-24-000763#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":111400.0,"shares_display":"111,400","price_per_share":0.73,"price_display":"0.73","price_state":"stated","total_value":81322.0,"total_display":"81,322.00","total_whole":"81,322","shares_owned_after":7859500.0,"shares_owned_after_display":"7,859,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-18","scope":"insider"},{"id":2541760,"accession":"0000947871-24-000763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000763","line_url":"/filing/0000947871-24-000763#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Passage BIO, Inc.","issuer_ticker":"PASG","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63100.0,"shares_display":"63,100","price_per_share":0.74,"price_display":"0.74","price_state":"stated","total_value":46694.0,"total_display":"46,694.00","total_whole":"46,694","shares_owned_after":7970900.0,"shares_owned_after_display":"7,970,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-18","scope":"insider"},{"id":2037685,"accession":"0000950170-24-107538","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-107538","line_url":"/filing/0000950170-24-107538","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":750000.0,"shares_display":"750,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":12000000.0,"total_display":"12,000,000.00","total_whole":"12,000,000","shares_owned_after":3158428.0,"shares_owned_after_display":"3,158,428","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider","n_lines":2},{"id":2268748,"accession":"0000947871-24-000702","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000702","line_url":"/filing/0000947871-24-000702","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Genesis GP LLC; OrbiMed Capital GP VII LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Genesis GP LLC","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":44.01,"price_display":"44.01","price_state":"stated","total_value":11002500.0,"total_display":"11,002,500.00","total_whole":"11,002,500","shares_owned_after":899212.0,"shares_owned_after_display":"899,212","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-13","filed_date":"2024-08-15","scope":"insider","n_lines":2},{"id":2942890,"accession":"0000947871-24-000627","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-24-000627","line_url":"/filing/0000947871-24-000627","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Advisors III Ltd; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Asia GP III, L.P.","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5188.0,"shares_display":"5,188","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":51880.0,"total_display":"51,880.00","total_whole":"51,880","shares_owned_after":4839412.0,"shares_owned_after_display":"4,839,412","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-17","scope":"insider","n_lines":3},{"id":2942876,"accession":"0000947871-24-000627","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-24-000627","line_url":"/filing/0000947871-24-000627","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Terns Pharmaceuticals, Inc.","issuer_ticker":"TERN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Advisors III Ltd; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC; OrbiMed Asia GP III, L.P.","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50976.0,"shares_display":"50,976","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":509760.0,"total_display":"509,760.00","total_whole":"509,760","shares_owned_after":4843421.0,"shares_owned_after_display":"4,843,421","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-17","scope":"insider","n_lines":3},{"id":2202162,"accession":"0000947871-24-000500","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000500","line_url":"/filing/0000947871-24-000500","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VII LLC; OrbiMed Genesis GP LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VII LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1033300.0,"shares_display":"1,033,300","price_per_share":22.14,"price_display":"22.14","price_state":"stated","total_value":22877262.0,"total_display":"22,877,262.00","total_whole":"22,877,262","shares_owned_after":7663349.0,"shares_owned_after_display":"7,663,349","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider","n_lines":2},{"id":7857089,"accession":"0000947871-23-000873","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000873","line_url":"/filing/0000947871-23-000873#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Galecto, Inc.","issuer_ticker":"GLTO","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP VII LLC; OrbiMed Advisors Israel II Ltd; OrbiMed Genesis GP LLC; OrbiMed Israel GP II, L.P.","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":535534.0,"shares_display":"535,534","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":401650.5,"total_display":"401,650.50","total_whole":"401,651","shares_owned_after":1510375.0,"shares_owned_after_display":"1,510,375","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-15","filed_date":"2023-08-17","scope":"insider"}],"collapsed":true,"next_cursor":"2023-08-15|7857089","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"Enliven Therapeutics, Inc.","url":"/issuer/0001672619","role":"Director, Ten percent owner","n_filings":6,"first_seen":"2020-03-16","last_seen":"2026-06-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001661998","name":"Q32 Bio Inc.","url":"/issuer/0001661998","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2026-06-01","last_seen":"2026-06-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001787297","name":"Passage BIO, Inc.","url":"/issuer/0001787297","role":"Ten percent owner","n_filings":17,"first_seen":"2020-03-03","last_seen":"2025-06-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001776111","name":"MBX Biosciences, Inc.","url":"/issuer/0001776111","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2024-09-17","last_seen":"2025-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001664710","name":"Keros Therapeutics, Inc.","url":"/issuer/0001664710","role":"Director","n_filings":2,"first_seen":"2020-04-13","last_seen":"2024-08-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001831363","name":"Terns Pharmaceuticals, Inc.","url":"/issuer/0001831363","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2021-02-09","last_seen":"2024-07-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001800315","name":"Galecto, Inc.","url":"/issuer/0001800315","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2020-11-04","last_seen":"2023-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001745020","name":"Theseus Pharmaceuticals, Inc.","url":"/issuer/0001745020","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2021-10-14","last_seen":"2023-07-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001797768","name":"Kinnate Biopharma Inc.","url":"/issuer/0001797768","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2020-12-04","last_seen":"2023-05-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001923840","name":"Third Harmonic Bio, Inc.","url":"/issuer/0001923840","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2022-09-21","last_seen":"2022-09-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001787306","name":"Arcutis Biotherapeutics, Inc.","url":"/issuer/0001787306","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2020-02-04","last_seen":"2022-06-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001817713","name":"Janux Therapeutics, Inc.","url":"/issuer/0001817713","role":"Director","n_filings":1,"first_seen":"2021-12-17","last_seen":"2021-12-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001808158","name":"Repare Therapeutics Inc.","url":"/issuer/0001808158","role":"Director","n_filings":6,"first_seen":"2020-06-25","last_seen":"2021-09-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001805890","name":"Fusion Pharmaceuticals Inc.","url":"/issuer/0001805890","role":"Director","n_filings":1,"first_seen":"2020-07-02","last_seen":"2020-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001609727","name":"Synthorx, Inc.","url":"/issuer/0001609727","role":"Ten percent owner","n_filings":1,"first_seen":"2018-12-13","last_seen":"2018-12-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001760648","retrieved_at":"2026-08-24T20:26:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}